sarcopenia glp 1 in the Era of GLP-1 Medications Muscle matters: the effects of

As key patents for leading products (such as semaglutide and tirzepatide) approach expiration in various countries, a new wave of companies, ranging from traditional generics manufacturers to complex peptide manufacturers and hybrid developers, is preparing to enter the market

So theres 130 million possible patients in the US alone but look at this chart here

[DOI] [PMC free article] [PubMed] [Google Scholar] 92.Garvey WT (2021) Long-term health benefits of intensive lifestyle intervention in the Look AHEAD study

I strongly recommend reaching out for a consultation if youre interested in learning more about what they can do for you

Fella Healths website displays logos for CBS, The New York Times , and NBC